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A B S T R A C T
Deterioration of neuromuscular junction (NMJ) integrity and function is causal to muscle atrophy and frailty,
ultimately hindering quality of life and increasing the risk of death. In particular, NMJ is vulnerable to ischemia
reperfusion (IR) injury when blood flow is restricted followed by restoration. However, little is known about the
underlying mechanism(s) and hence the lack of effective interventions. New evidence suggests that mitochon-
drial oxidative stress plays a causal role in IR injury, which can be precluded by enhancing mitochondrial protein
S-nitrosation (SNO). To elucidate the role of IR and mitochondrial protein SNO in skeletal muscle, we utilized a
clinically relevant model and showed that IR resulted in significant muscle and motor nerve injuries with evi-
dence of elevated muscle creatine kinase in the serum, denervation at NMJ, myofiber degeneration and re-
generation, as well as muscle atrophy. Interestingly, we observed that neuromuscular transmission improved
prior to muscle recovery, suggesting the importance of the motor nerve in muscle functional recovery. Injection
of a mitochondria-targeted S-nitrosation enhancing agent, MitoSNO, into ischemic muscle prior to reperfusion
reduced mitochondrial oxidative stress in the motor nerve and NMJ, attenuated denervation at NMJ, and re-
sulted in accelerated functional recovery of the muscle. These findings demonstrate that enhancing mitochon-
drial protein SNO protects against IR-induced denervation at NMJ in skeletal muscle and accelerates functional
regeneration. This could be an efficacious intervention for protecting neuromuscular injury under the condition
of IR and other related pathological conditions.
1. Introduction
Neuromuscular junction (NMJ) is a unique microdomain where a
motor neuron and skeletal muscle fiber interface to coordinate volun-
tary muscle contractions. Conditions in which neuromuscular function
is compromised, such as amyotrophic lateral sclerosis [1], aging [2],
muscular dystrophies [3] and traumatic injuries [4], are often char-
acterized by deterioration of NMJ. In particular, following certain types
of surgeries or as a first response to traumatic injury, in which a tour-
niquet is used to control blood flow, skeletal muscle and motor nerves
are often damaged by ischemia reperfusion (IR), caused by interruption
in tissue perfusion and subsequent restoration of blood flow. In addition
to muscle weakness and atrophy [5,6], IR injury can cause irreversible
nerve and NMJ damage [7,8], all of which hinder functional recovery of
the affected skeletal muscle. However, we know little about the un-
derlying mechanism(s) of IR-induced neuromuscular damage, and
hence there is currently no reliable and effective intervention [9–11].
Mitochondria are enriched on the pre- and post-synaptic sides of
NMJ [12,13] and are essential for NMJ development, stability, and
neurotransmission [14–16]. Perturbations that alter mitochondrial en-
ergy production, Ca2+ buffering, or increase oxidative stress, play a
causal role in NMJ degradation and neuromuscular dysfunction [1,17].
In the context of IR injury, excessive generation of mitochondria-de-
rived reactive oxygen species (mtROS), which leads to mitochondrial
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oxidative stress, are considered central to the initiation and exacerba-
tion of IR pathology [18,19]. Mitochondria transfer electrons through
the electron transport system (ETS) to drive the formation of adenosine
triphosphate (ATP), which serves as chemical energy storage used di-
rectly for all biological processes [20]. During normal mitochondrial
oxidative respiration, a small percentage of electrons escape the ETS
and form superoxide [21], which is rapidly scavenged and detoxified by
the resident antioxidant enzymes and molecules [22,23]. During
ischemia, tissue oxygen supply is discontinued and mitochondrial oxi-
dative respiration suspended [24]. Depending on the duration of
ischemia, there will be insufficient production of ATP and accumulation
of ADP as well as other intermediate metabolites and reducing
equivalents, such as NADPH and succinate [25,26]. Upon reperfusion,
these metabolic buildups cause a surge of mtROS from the ETS [21,27].
When the production of mtROS exceeds the capacity of the mitochon-
drial antioxidant defense system, it results in oxidization of cellular
components (e.g. DNA, protein and lipid, etc.), causing tissue damage
and dysfunction and/or cell death [28,29]. Furthermore, mtROS may
further damage mitochondrial structure and impair function [30],
leading to a vicious cycle [29,30]. Therefore, prevention of mtROS
production or neutralization of the reactive molecules may prove be the
most efficacious intervention against IR injury.
Nitric oxide (NO) and its derivatives have been found to interact
with the mitochondrial proteome, modulating respiration and pro-
viding cytoprotective effects [33] in the context of IR injury. In parti-
cular, mitochondrial protein S-nitrosation (SNO) reversibly inhibits
mitochondrial respiration, prevents mtROS production by reverse
electron transfer (RET) at complex I of the ETS [25], and shields protein
cysteine residues from irreversible oxidation [34,35]. Enhancement of
mitochondrial SNO either by ischemic preconditioning [36] or treat-
ment with NO donor [37–40] has been found to be protective in models
of myocardial infarction; however, whether such strategies are applic-
able for conditions of neuromuscular injuries in skeletal muscle and
how enhanced mitochondrial SNO might lead to the protection are
unknown. In the present study, we utilized a clinically relevant model
of tourniquet-induced IR injury in mouse hindlimb to test whether
pharmacological augmentation of mitochondrial SNO could preserve
muscle and/or motor nerve structural integrity and function with im-
proved recovery from IR. We employed the state-of-the-art mitochon-
drial reporter technology to elucidate the underlying mechanism(s) of
the pathology of IR injury with a focus on mitochondrial oxidative
stress in both adult skeletal myofibers and motor nerves.
2. Results
2.1. Tourniquet-induced IR in skeletal muscle causes both nerve and muscle
damages
To determine the impact of IR injury on nerve and muscle function,
we applied a tourniquet above the right femur of a mouse to induce
ischemia for 1 h, a duration compatible with the clinical guidelines,
followed by removal of the tourniquet to initiate reperfusion [41]. We
performed a 28-day longitudinal study, in which we measured the
maximal tetanic force production of the planter flexors in vivo via nerve
stimulation or direct muscle stimulation. These protocols provide in-
sight into neuromuscular transmission and force generating capacity of
the muscle, respectively [9,42]. In un-injured mice (sham), force pro-
duction resulting from nerve and muscle stimulations was indis-
tinguishable (Fig. 1a). However, at day 7 following IR injury, forces
generated by nerve and muscle stimulations were reduced by 80% and
50%, respectively, compared to the sham control (Fig. 1a and
Supplemental Table 1). The additional deficit in force production via
nerve stimulation is indicative of impaired neuromuscular transmission.
At day 14 post-injury, nerve stimulation-elicited force production be-
came equal to that produced by muscle stimulation while the latter had
not changed. By day 28, force production by muscle and nerve
stimulation significantly increased and had recovered to the level of
sham control mice when normalized to muscle weight (Fig. 1b). In a
parallel, terminal experiment over the same time course, we confirmed
that reduction in force between days 7 and 14 even when we normal-
ized the force by muscle mass, suggesting its independency of muscle
atrophy (Supplemental Fig. 1). These findings demonstrate that IR
causes injury to nerve and muscle, and neuromuscular transmission
recovers prior to functional recovery of muscle.
To assess muscle injury, we measured serum creatine kinase (CK)
activity, a marker of muscle damage [43,44]. CK was elevated 4-fold
between 3 and 12 h post-IR compared to the sham control mice before
returning to the baseline after 1 day (Fig. 1c). This initial, transient
increase in CK activity suggests that a single damaging event to the
muscles. Muscle damage was further confirmed by reduced gastro-
cnemius wet weight to 40% of the sham control at day 14 (Fig. 1d).
Furthermore, histological analysis by hematoxylin and eosin (H&E)
staining revealed a gradual increase of centrally located myonuclei, a
marker of muscle regeneration [45], over the 28-day experimental
period (Fig. 1e), suggesting ongoing regeneration.
Finally, we examined innervation at neuromuscular junctions
(NMJ) in the middle portion of the plantaris muscle. Muscle contraction
begins at NMJ where neurotransmitter acetylcholine is released by the
motor nerve (pre-synaptic) and binds to its receptor on the muscle
(post-synaptic), initiating a cascade of events that lead to contraction
and force generation [46]. Impairment of structure and/or function on
either pre- or post-synaptic side of NMJ will impair muscle contraction
[47]. We assessed NMJ innervation by measuring the overlap of im-
munoreactivity of the presynaptic markers β-III tubulin (Tuj1) and sy-
naptic vesicle proteins (SV2) with the post-synaptic acetylcholine re-
ceptor (AchR) detected by α-bungarotoxin (α-BTX). We found a
significant reduction in Tuj1/SV2-α-BTX overlap at 3 h following IR
injury compared to the sham control. This was followed by a partial
recovery at day 28 (Fig. 1f). Importantly, the reduction in Tuj1/SV2-α-
BTX overlap was due to a loss of the immunoreactivity of the pre-sy-
naptic structures, indicative of NMJ denervation. These data suggest
that 1-h tourniquet application followed by reperfusion in mouse hin-
dlimb leads to both muscle and nerve injury, and temporal findings also
raise the possibility that functional recovery of skeletal muscle may, at
least in part, depend on motor nerve recovery.
2.2. Ischemia-reperfusion causes mitochondrial oxidative stress in skeletal
muscle, motor nerve, and NMJ
Since mtROS production is considered central to IR injury [18,19],
we sought to determine whether tourniquet-induced IR causes mi-
tochondrial oxidative stress within the neuromuscular system. To ad-
dress this question we crossed CAG-CAT-MitoTimer mice with CAG-
CreERT2 mice to obtain MitoTimer reporter mice with global inducible
expression ofMitoTimer, a novel redox-sensitive mitochondrial-targeted
reporter gene [32,48,49]. We observed a significant increase in Mito-
Timer red: green ratio in plantaris muscle (Fig. 2a) and sciatic nerve
(Fig. 2b) 3 h following IR injury, emblematic of increased mitochon-
drial oxidative stress [32,48,49]. To assess the mitochondrial oxidative
stress at NMJ we utilized α-BTX to identify NMJ and imaged areas in
which MitoTimer and α-BTX overlapped (Fig. 2c). In accordance with
electron microscopy studies that show an enrichment of mitochondria
at NMJ [14], MitoTimer fluorescence was concentrated in a similar
pattern as α-BTX. Moreover, MitoTimer red: green ratio in this region
was significantly greater 3 h following IR as compared to those in the
sham control mice, providing the first quantitative measurement of
oxidative stress in the mitochondria of NMJ in vivo. Clustering of Mi-
toTimer with α-BTX was confirmed to be indicative of mitochondria at
the NMJ using MitoTracker and α-BTX (Supplemental Fig. 2a and 2b).
These findings demonstrate that IR causes mitochondrial oxidative
stress in plantaris muscle, sciatic nerve and NMJ.
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2.3. MitoSNO protects motor nerve function, leading to improved functional
regeneration of skeletal muscle
Since mitochondrial SNO has been found to reversibly depress mi-
tochondrial respiration, reduce mtROS generation and shield cysteine
residues from oxidation [50], we investigated whether promoting mi-
tochondrial SNO was sufficient to attenuate muscle and/or nerve da-
mage. We administered saline, MitoSNO (a mitochondrial targeted S-
nitrosothiol) or MitoNAP (the thiol precursor of MitoSNO for the non-
SNO effects of MitoSNO) [39]. We confirmed that MitoSNO treatment
had to be administrated prior to reperfusion to be effective
(Supplemental Fig. 3a and 3b), consistent with the previous findings in
the heart [38]. To determine the consequence of MitoSNO treatment
following IR injury, we measured tetanic force production in vivo by
muscle or nerve stimulation. At day 7 post-IR, force production via
nerve stimulation was significantly greater in MitoSNO-treated muscles
compared to MitoNAP- or saline-treated muscles (Fig. 3a), providing
the first evidence of motor nerve. Ischemic-preconditioning has pre-
viously shown not effective in preventing neuromuscular dysfunction
induced by IR [9,51]. Conversely, force production induced by direct
muscle stimulation was reduced similarly in saline-, MitoNAP- and
MitoSNO-treated hindlimb muscles compared to the sham control
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Fig. 1. Tourniquet-induced IR in skeletal muscle causes both nerve and muscle damages. To determine the consequence of IR on skeletal muscle and motor nerve fibers a rubber
band was applied to induce ischemia and released after 1 h to initiate reperfusion. Muscle function and muscle injury as well as motor nerve innervation were assessed at indicated time
points over 28 days. (a) Comparison of tetanic force production of plantar flexors by nerve stimulation or muscle stimulation after IR at multiple time points (** and *** denote p < 0.01
and p < 0.001, respectively, n=6). Other statistically significant comparisons are presented in Supplemental Table 1; (b) Specific tetanic force 28 days following injury; (c) Serum
creatine kinase activity (* and *** denote p < 0.05 and p < 0.001, respectively, n= 3–5); (d) Wet weight of GA muscle normalized by tibia length (mm). (*, ** and *** denote
p < 0.05, p < 0.01 and p < 0.001, respectively, n= 6–8); (e) Representative light microscope images of H&E stained skeletal muscle cross sections and percentage of fibers with
centralized nuclei (scale bar = 100 µm, * and *** denote p < 0.05 and p < 0.001, respectively, n= 3–5); (f) Representative confocal images of α-bungarotoxin (α-BTX, red) and beta
III-tubulin/synaptic vesicle protein-2 (Tuj1/SV2, green) and percentage of denervated NMJ following IR (scale bar = 50 µm and 20 µm for the top panel and bottom enlarged panel,
respectively, ** denotes p < 0.01, n= 5–7). Data are represented as mean ± SEM.
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(Fig. 3a), suggesting an equal level of damages to the muscles under
these conditions. At day 14 following injury, neuromuscular transmis-
sion had recovered in all groups, but MitoSNO-treated muscles gener-
ated significantly greater force, suggesting that MitoSNO treatment
promotes functional regeneration of skeletal muscle following IR injury.
Next, we assessed muscle mass and found a similar reduction (~
40%) in of gastrocnemius muscle wet weight in saline-, MitoNAP-, and
MitoSNO-treated groups at 14 days post-IR compared to the sham
control (Fig. 3b). Analysis of specific force revealed that specific force
production in MitoSNO-treated muscle was indistinguishable from that
of the sham control mice and was significantly higher than saline- and
MitoNAP- treated muscles (Fig. 3c). These data indicate that MitoSNO
treatment did not lead to a complete recovery of muscle mass but a
complete recovery of muscle contractile function. Additionally, a lack
of protection by administration of MitoNAP suggests that the protection
by MitoSNO treatment is due to the presence of the NO moiety, which
transnitrosates cysteine residues, rather than the antioxidant properties
of the free thiol. Thus, we focused on MitoSNO in the subsequent ex-
periments.
To confirm that intramuscular injection of MitoSNO during
ischemia enhances mitochondrial protein SNO, we assessed mitochon-
drial protein SNO in grastrocnemius muscle and sciatic nerve using a
biotin switch assay [52]. Levels of SNO of ETS complex I (NADH oxi-
doreductase 75 kDa subunit), II (Succinate dehydrogenase iron-sulfer
subunit B), III (Cytochrome c oxidase subunit 1), and V (ATP synthase
subunit α) were significantly elevated compared to saline-treated
muscle and the muscle of the sham control mice (Fig. 3d). Similar
findings were obtained in sciatic nerve (Fig. 3e). These findings validate
that intramuscularly injection of MitoSNO prior to reperfusion en-
hances SNO of mitochondrial proteins in skeletal muscle and motor
nerve. Taken together, these findings suggest that MitoSNO treatment
enhances SNO of mitochondrial proteins in both skeletal muscle and
motor nerve, but effectively protects motor nerve and/or NMJ, leading
to improved contractile function recovery post-IR injury.
2.4. MitoSNO treatment preserves innervation at NMJ following IR
To elucidate the impact of mitochondrial SNO on neuromuscular
system, we subjected mice to IR with or without treatment with
MitoSNO. Following IR, MitoSNO-treated muscle displayed a preserved
overlap of α-BTX and Tuj1/SV2, suggesting protection against IR-in-
duced NMJ denervation (Fig. 4a). This difference of innervation at NMJ
between saline- and MitoSNO-treated muscles was maintained up to
day 14 days post-IR. Additionally, the number of muscle fibers ex-
pressing neural cell adhesion molecule (Ncam), a marker of denervation
[53], was increased at day 14 in saline-treatment muscles compared to
the sham control, which was profoundly attenuated by MitoSNO
treatment (Fig. 4b). These findings provide additional evidence for the
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Fig. 2. Ischemia-reperfusion causes mitochondrial oxidative stress in skeletal muscle, motor nerve, and NMJ. To determine the impact of IR on mitochondrial oxidative stress
MitoTimer transgenic mice were subjected to IR followed by 3 h of reperfusion. Representative confocal images and quantification of MitoTimer red:green in (a) plantaris muscle and (b)
sciatic nerve (scale bar = 50 µm, * and ** denote p < 0.05 and p < 0.01, respectively, n= 3–4); (c) Representative images of α-BTX (gray) and MitoTimer (green and red) coloca-
lization with NMJ and quantification of MitoTimer red:green ratio at the NMJ (scale bar = 5 µm, * denotes p < 0.05, n= 3). Data are represented as mean ± SEM.
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protective effect of MitoSNO on NMJ from IR injury.
To assess the impact of MitoSNO treatment on muscle damage, we
measured serum CK activity 3 h after IR and observed a 6-fold increase
in serum CK activity (Fig. 4c) in Saline and MitoSNO groups compared
with the Sham control group, suggesting a comparable degree of muscle
damage. Histological analysis at day 14 revealed a significant increase
in centralized nuclei in Saline group compared to the Sham control
group, while MitoSNO treatment did not lead to a statistically sig-
nificant reduction (Fig. 4d). Together, these data show that enhancing
mitochondrial SNO by intramuscular injection of MitoSNO prior to
reperfusion protects against IR-induced denervation at NMJ, which
leads to overall improved functional recovery of muscle following IR.
2.5. MitoSNO treatment reduces IR-induced mitochondrial oxidative stress
in the motor nerve
To determine whether reduction of mitochondrial oxidative stress
underlies MitoSNO-mediated protection of the nerve function and in-
nervation at NMJ, we subjected MitoTimer reporter mice to IR injury. IR
injury led to a significant increase in MitoTimer red: green ratio in
plantaris muscle (Fig. 5a), sciatic nerve (Fig. 5c) and NMJ (Fig. 5e) 3 h
following IR, indicative of increased mitochondrial oxidative stress in
both muscle fibers and motor nerve in the hindlimb. It is worthy noti-
cing that mitochondrial oxidative stress has been reported under other
conditions using this technology [32,49,54]. Treatment with MitoSNO,
however, significantly attenuated the increase of MitoTimer red: green
ratio in the sciatic nerve (Fig. 5c) and NMJ (Fig. 5e), but this effect in
plantaris muscle was not statistically significant (Fig. 5a). Since the
redox sensitive residue of MitoTimer is tyrosine 67 [55], which cannot
undergo SNO, the reduction of MitoTimer red: green ratio in sciatic
nerve following MitoSNO treatment is likely a consequence of reduced
mtROS rather than direct shielding by SNO. We observed similar in-
creases of lipid peroxidation induced by IR as indicated by western blot
analysis of 4-hydroxynonenal (4HNE), a marker of oxidative stress, in
mitochondria isolated from plantaris muscle (Fig. 5b) and sciatic nerve
(Fig. 5d), which was only reduced in sciatic nerve by MitoSNO treat-
ment. Collectively, findings obtained by two independent assay systems
indicate that MitoSNO treatment reduces IR-induced mitochondrial
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Fig. 3. MitoSNO preserves neuromuscular func-
tion and facilitates recovery of muscle force. To
determine whether enhancement of mitochondrial
protein SNO could attenuate IR injury to the nerve
and/or skeletal muscle, saline, MitoSNO or MitoNAP
were injected intramuscularly to ischemic muscle
5 min prior to the release of the tourniquet.
Mitochondrial protein SNO, nerve and muscle func-
tion, and muscle mass were measured at indicated
time points. (a) Maximum tetanic force produced by
nerve stimulation or muscle stimulation at days 7
and 14 following IR (** and *** denote p < 0.01
and p < 0.001, respectively, n= 6–9); (b) Mass of
gastrocnemius muscle at day 14 normalized to tibia
length (mm) (*** denotes p < 0.001, n=6); (c)
Nerve-stimulated specific force at day 14 (*** de-
notes p < 0.001, n=6). Immunoblots and quanti-
fication of complexes I, II, III and V of the ETS from
(d) gastrocnemius muscle (e) and sciatic nerve fol-
lowing biotin switch assay. Control of SNO reaction
was provided by incubation of tissues in vitro with
either MitoSNO or MitoSNO + Dithiothreitol. (*, **,
and ***, denote p < 0.05, p < 0.01, and
p < 0.001, respectively, n= 3–5). Data are re-
presented as mean ± SEM.
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oxidative stress in the motor nerve leading to preservation of motor
nerve/NMJ structure and neuromuscular transmission, facilitating
functional rehabilitation of the muscle following IR injury.
3. Discussion
Impaired neuromuscular function, due to NMJ injury, is central to a
number of diseases and traumas that affect muscle mass and force
production, causing impairments in voluntary movement [1–4] While
the mechanism(s) underlying deterioration in neuromuscular function
and NMJ are still being uncovered, excessive generation of mtROS and
consequential oxidative stress predominate [1,7,8,56] However, until
now, there has been no therapeutics that directly target mitochondria to
preserve neuromuscular integrity. In this study, we sought to elucidate
the consequence(s) of IR injury on mitochondrial oxidative status and
its impact on skeletal muscle and motor nerve function by employing a
model directly relevant to usage of a tourniquet to control blood flow in
certain clinical procedures in humans. We obtained functional, mor-
phological, and biochemical evidence that recapitulates many of the
consequences of IR injury observed in human skeletal muscle and motor
nerves [7,57]. Furthermore, we found that treatment with MitoSNO, a
mitochondria-targeted molecule that enhances SNO, protected motor
nerves against IR injury and improved functional regeneration of the
affected skeletal muscles. These findings identify intramuscular injec-
tion of MitoSNO as an effective intervention against IR injury and
highlight the importance of nerve function on muscle recovery from IR
injury.
Accumulation of oxidative stress within the NMJ mitochondria is
thought to play a causal role in neuromuscular dysfunction [1]. Despite
the recognized importance of mitochondria in neuromuscular function,
technologies for assessment of mitochondrial morphology, function,
and/or integrity at NMJ have been limited to electron microscopy
[14,58], in vitro cell culture [59], or extrapolation of studies conducted
in separate categories of nerve synapses using a variety of fluorescent
probes [15]. These aforementioned approaches, however, do not pro-
vide insight into mitochondrial oxidative stress in NMJ in vivo. Here,
we developed and utilized a novel transgenic mouse line, in which
MitoTimer, a reporter gene for reporting mitochondrial oxidative stress,
is inducibly expressed in all tissues of the body. We discovered that IR
injury caused a significant increase of mitochondrial oxidative stress in
the motor nerve and skeletal muscle. Taking advantage of fluorescently
conjugated α-BTX, we ascertained MitoTimer signal hence mitochon-
drial oxidative stress at NMJ. Using this novel approach, we obtained
clear evidence of increased mitochondrial oxidative stress in these
discrete areas following IR injury. Together, these findings provide the
first direct measurement of mitochondrial oxidative stress in NMJ.
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Fig. 4. MitoSNO attenuates denervation of NMJ. To elucidate the consequence of MitoSNO treatment on NMJ innervation and muscle injury we subjected ischemic hindlimb muscle to
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n= 4); (c) Serum creatine kinase activity 3 h following IR (*** denotes p < 0.001, n=6); (d) Representative images of H&E stained transverse sections of skeletal muscle and
quantification of percentage of fibers with centralized nuclei 14 days following IR (scale bar = 50 µm, ** denotes p < 0.01, n= 4). Data are represented as mean ± SEM.
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Aberrant mtROS production upon rapid reactivation of mitochon-
drial respiration during reperfusion is critical for initiation and propa-
gation IR injury [60]. Given the proximity to the primary site of mtROS
production, mitochondrial macromolecules are especially vulnerable to
oxidative damage [61]. Accumulation of damaged mitochondrial pro-
teins contributes to mitochondrial dysfunction, which effectively im-
pairs tissue function and recovery [31]. Mitochondrial respiration can
be regulated by redox-based protein modifications of cysteine residues.
Particularly, enhanced SNO of proteins of ETS [27,38,62] and tri-
carboxylic acid (TCA) cycle [24,36] have been found to elicit cyto-
protective effects against IR injury. For example, studies of myocardial
infarction reveal that SNO of Cys39 on the ND3 subunit of complex I by
MitoSNO potently protects the heart from IR injury by slowing mi-
tochondrial respiration and mtROS production during reperfusion
[38,39]. Informed by this precedent, we asked whether treatment with
MitoSNO could enhance SNO of ETS proteins and attenuate
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Fig. 5. MitoSNO reduces IR-induced mitochon-
drial oxidative stress in the motor nerve. To de-
termine the effect(s) of MitoSNO treatment on mi-
tochondria oxidative stress in the motor nerve and
skeletal muscle fibers, we assessed MitoTimer red:-
green via confocal microscopy and 4HNE in isolated
mitochondria from the plantaris muscle and sciatic
nerve 3 h following injury. (a) Representative con-
focal images and quantification of Mitotimer red:-
green ratio of plantaris muscle (scale bar = 50 µm, *
and ** denote p < 0.05 and p < 0.01, respectively,
n= 7); (b) Representative immunoblot and quanti-
fication of 4HNE in mitochondria isolated from
plantaris muscle (* denotes p < 0.05, n= 6); (c)
Representative confocal images and quantification of
Mitotimer red:green ratio of sciatic nerve (scale bar
= 50 µm, *, **, and *** denote p < 0.05, p < 0.01,
and p < 0.001, respectively, n= 7), (d)
Representative immunoblot and quantification of
4HNE in mitochondria isolated from sciatic nerve (*
denotes p < 0.05, n= 3); (e) Representative images
of α-BTX (gray) and MitoTimer (green and red) co-
localization with NMJ and quantification of
MitoTimer red:green ratio at the NMJ (scale bar
= 5 µm, * denotes p < 0.05, n= 4). Data are re-
presented as mean ± SEM.
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mitochondrial oxidative stress following IR injury. Our findings of en-
hanced SNO of the 75-kda subunit of complex I, a site of NADH oxi-
dation, and complex II, the entry site of electrons from succinate to
FADH2 are consistent with the findings in cardiomyocytes [38,39].
Furthermore, administration of MitoSNO resulted in reduced mi-
tochondrial oxidative stress in the sciatic nerve and preserved motor
nerve function and NMJ innervation. Due to the scarce tissue avail-
ability, we could not ascertain whether MitoSNO treatment elicits the
protection in motor nerve through SNO of Cys39 or other mitochondrial
proteins that are susceptible to SNO in this study. It is worth noticing
that sciatic nerve has greater induction of SNO of complex III than
skeletal muscle in our model. However, there is currently no evidence
that this change has any functional significance. We also acknowledge
that this study has primarily focused on limited number of mitochon-
drial proteins. Enhanced SNO of other mitochondrial ETC proteins may
contribute the protection. Future research should pinpoint the func-
tional site of MitoSNO action in ETC and explore the possibility of SNO
of other protein for the protection in motor nerve, which will aid in the
development targeted therapeutics.
The mechanism by which enhancing mitochondrial protein SNO
protects against IR is not entirely clear, particularly because ~ 1% of
the cysteines of the mitochondrial proteome are available for SNO
[39,62]. SNO has been found to shield critical cysteine thiols from ir-
reversible oxidation and alter protein activity [36,50,62]. In addition to
reversible modulation of enzyme activity, SNO shields cysteine residues
from irreversible oxidation, which has been shown to protect proteins
that are vulnerable to oxidant-mediated inactivation in the heart [67].
Thus, it is likely that MitoSNO mediated protection to the motor nerve
is a synergistic effect of enhanced SNO of multiple ETS proteins, ulti-
mately reducing mitochondrial oxidative stress and preserving mi-
tochondrial function.
Loss of tissue viability and function are among the consequences of
IR, and thus, attenuation of mitochondrial oxidative stress should curb
these abnormalities. Indeed, we obtained substantial evidence that
treatment with MitoSNO preserved nerve function following IR injury,
as determined by the discrepancies between the forces elicited by nerve
stimulation and direct muscle stimulation. This is most likely attribu-
table to the aforementioned reduction in mitochondrial oxidative stress,
which would maintain nerve function extending from the axon to the
NMJ. Such reasoning is bolstered by other studies in models of diabetic
neuropathy and ALS, in which administration of antioxidants or anti-
oxidant gene mimetics attenuated loss of motor nerve conduction [68]
and enhanced survival of motor neurons [69], respectively. However,
additional studies are needed to parse the precise mechanism, by which
mitochondrial oxidative stress abrogates nerve function upon IR injury.
Despite the potent protection of motor nerve by MitoSNO treatment,
initial damage to skeletal muscle was not prevented. This lack of pro-
tection against skeletal muscle injury per se suggests that muscle da-
mage may be mediated by a mechanism(s) independent of mtROS, such
as ROS production from non-mitochondrial sources [70], and/or en-
hanced calpain activity [71]. Other studies have shown that necrotic
and apoptotic cell death pathways in skeletal muscle are rapidly in-
itiated during ischemia, and the degree of activation of cell death
pathway is proportional to the duration of ischemia [72]. Thus, Mi-
toSNO, which we administered immediately prior to reperfusion, would
not likely affect damage occurred during ischemia. Importantly, our
data that functional regeneration of muscles treated with MitoSNO
exceeded that of the other groups suggests that the protection is
mediated by a process other than direct protection against initial
muscle injury.
Both the maintenance of muscle mass and contractile function under
normal condition and the recovery following injury are highly affected
by neuromuscular activity as well as neurotrophic factors. The influ-
ence of nerve on muscle functional regeneration are multifold, im-
pacting muscle metabolism [73], sarcomeric organization [74] and
muscle fibrillation [75]. Indeed, functional recovery of muscle
following nerve crush injury has been previously shown to be accom-
plished, albeit gradually, only after neural input recovers [76]. We
found that nerve function and NMJ innervation were preserved 7 days
following treatment with MitoSNO when compared to MitoNAP- or
saline-treated groups. Of great interest is the finding that MitoSNO
treatment led to a more rapid recovery of contractile function without
an appreciable reinnervation of the NMJ at day 14. These data suggest
that the increase in force production between day 7 and 14 in MitoSNO-
treated muscles is due to functional regeneration of the muscle. It is
therefore likely that the accelerated improvement in muscle function is
attributable to the preserved NMJ innervation and function during the
initial phase of IR. Therefore, preservation of NMJ accelerates func-
tional regeneration of skeletal muscle from IR injury.
In conclusion, our studies demonstrate that treatment with mi-
tochondria-targeted S-nitrosythiol MitoSNO prior to reperfusion at-
tenuates IR-induced denervation at NMJ and preserves neuromuscular
function, which facilitate functional regeneration. Our findings high-
light a here unto unappreciated role of the physiological consequences
of enhanced SNO of mitochondrial proteins at NMJ and prove the
feasibility of intramuscular injection of MitoSNO as an effective inter-
vention against IR injury in skeletal muscle as an organ.
4. Material and methods
4.1. Animals
All animal procedures were conducted under the approval of the
UVa animal care and use committee. Male C57Bl/6 between 9 and 12
weeks were obtained from Jackson Laboratory (Bar Harbor, ME).
MitoTimer transgenic mice were generated by subcloning the Mitotimer
coding region in an inducible expression vector downstream from LoxP-
flanked chloramphenicol acetyltransferase (CAT) coding sequence [77]
with a stop codon under the control of CMV early enhancer/chicken β
actin (CAG) promoter [78]. We called this construct pCAG-CAT-Mito-
Timer, which allows for inducible expression of MitoTimer following
expression of the Cre recombinase. When we co-transfected pCAG-CAT-
MitoTimer with pCMV-Cre, an expression vector of Cre under the con-
stitutively active CMV promoter, we observed MitoTimer expression
while co-transfection with an empty vector, pCI-neo, showed no ex-
pression of MitoTimer). We then used the isolated DNA fragment con-
taining the expression unit for pro-nuclei injection and a generated
transgenic mouse line in C57BL/6 background, call CAG-CAT-MitoTimer
mice. After we crossbred the CAG-CAT-MitoTimer mice with a global
inducible Cre mouse line, CAG-Cre-ERT2, we injected the adult global
inducible MitoTimer mice (CAG-CAT-MitoTimer;CAG-Cre-ERT2) with
tamoxifen (40mg/kg, i.p.) daily for 7 days and observed expression of
MitoTimer in the skeletal muscle, heart, lung, liver, kidney and brain.
4.2. Ischemia-reperfusion injury
IR injury was induced by application of a 4.0-oz 1/8’ orthodontic
rubberband (DENTSPLY GAC International Inc. 11-102-03) above the
greater tronchanter of the femur using a McGivney Hemmrohidal
Ligator as previously described [79]. The tourniquet was removed after
1 h to induce reperfusion. Experiments were performed at various time
points ranging from 0 h (end of ischemia) to 28 days following IR.
4.3. Creatine kinase activity
Creatine kinase activity was measured following the manufacturer's
instructions of a commercially available kit (Sigma Aldrich MAK116).
Blood was collected from the tail, incubated at RT for 30min then spun
at 1,500 × g at 4 °C for 30min. The clear portion was removed (serum)
and the clot was discarded. Samples were aliquoted and stored at
− 80 °C until needed at which point they were thawed on ice and di-
luted 1:10 in dH2O prior to assay execution.
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4.4. In vivo muscle function
Maximal isometric torque of the plantarflexors was assessed as
previously described [54]. Under anesthesia (1% isofluorane in oxygen)
mice were placed on a heated stage in the supine position and the right
foot was secured to foot-plate attached to a servomotor at 90° relative to
the immobilized knee (Model 300C-LR; Aurora Scientific, Ontario, Ca-
nada). For nerve stimulated contractions (Nerve Stim); Teflon coated
electrodes were inserted percutaneously on either side of the sciatic
nerve ~ 1 cm proximal to the knee joint. For direct muscle stimulation
(Direct Stim); electrodes were inserted into the proximal and distal ends
of the gastrocnemius muscle. Peak isometric torque (mNm), which is
referred to as force, was achieved by varying the current delivered to
the nerve or muscle and keeping the following parameters constant:
10 V electric potential, 200 Hz stimulation frequency, 300ms stimula-
tion duration, and 0.3ms pulse duration. To account for differences in
body size among mice, force was normalized by body mass (g), which
did not change over the experimental time period. Specific force was
calculated by dividing absolute force by plantarflexor wet weight (mg).
4.5. Drug treatment
MitoSNO and MitoNAP, generous gifts from Michael Murphy, were
dissolved in 0.9% sterile saline, filtered through 2 μM filter, kept on ice
and protected from light immediately prior to the experiments. Saline,
MitoSNO or MitoNAP were injected into the tibialis anterior (100 µL)
and GA (150 µL) after 55min of ischemia.
4.6. Mitotimer analysis
MitoTimer is a mitochondria targeted reporter gene that shifts
emission from green (Fitc excitation/emission 488/518 nm) to red
(Tritc excitation/emission 543/572 nm) upon oxidation. Mitotimer is a
useful tool to measure mitochondrial oxidative stress (red: green ratio)
[32,49]. Images were acquired as previously described [32,49]. Briefly,
the sciatic nerve (SN) and plantaris muscle (PL) were harvested from
the hindlimb and fixed in 4% paraformaldehyde (PFA) for 20min,
washed with phosphate buffered saline (PBS), and mounted on a gelatin
coated slide with 50/50 PBS glycerol. Images were acquired via con-
focal microscopy using Olympus Fluoview FV1000. Quantification of
the red: green ratio of plantaris muscle and sciatic nerve using a
custom-designed MatLab-based algorithm. For MitoTimer and AchR
analysis, plantaris muscle were first prepared as described above then
incubated with α-BTX prior to confocal imaging. Analysis of MitoTimer
at the NMJ was done manually using ImageJ. All images were acquired
with identical acquisition parameters for the respective tissue types.
4.7. NMJ analysis
NMJ area and occupancy were assessed as previously described
[2,80]. Briefly, the plantaris muscle was removed and fixed in 4% PFA
for 20min, permeabilized in 3% Triton-X100 in PBS for 30min and
blocked in 1% Triton-X100+4% fatty acid-free BSA for 60min at room
temperature. Muscles were then incubated with primary antibodies
against Tubulin β-III (Tuj1, Covance 801201) 1:100 and synaptic ve-
sicle 2A (SV2, Abcam ab32942) 1:50 overnight at 4 °C. Muscles were
washed 3× with PBS then incubated with Goat-anti-Rabbit-FITC and
Goat-anti-Mouse-FITC secondary antibodies for 2 h at RT. Alexa Fluor
647 conjugated α-bungarotoxin (1 μg/mL) (Thermo Scientific B35450)
was added to the secondary antibodies after 1.5 h. At the end of 2 h,
muscles were rinsed 3× with PBS then mounted on gelatin coated sides
using Vectashield (Vector Laboratories H-1000). Images were acquired
using Olympus Fluoview FV1000. To assess the whole NMJ, Z-stacks
were acquired using both 20× and 60× objectives. Only NMJs com-
pletely en face acquired at 60× were analyzed. Maximum intensity Z-
stacks were reconstructed in ImageJ (National Institutes of Health) and
underwent the following corrections in the order listed: background
subtraction (50.0 pixels), despeckling, application of a Gaussian blur
(2.0 radius) and conversion to binary. Occupancy was determined by
dividing the area of the presynaptic structures by the area of post sy-
naptic structures (pre μm2/post μm2 × 100). Denervation is defined as
the percentage of total NMJs in which the occupancy is> 5%.
4.8. Cryosectioning and staining
Immediately after dissection the plantaris muscle was embedded in
a mold filled with Tissue Tek optimal cutting temperature compound
then frozen in an isopentane slurry cooled by liquid nitrogen.
Transverse sections were cut using a cryostat (5 µm), mounted on po-
sitively charged slides, air dried, then stored at− 80 °C. Cryosections of
plantaris muscle stained with hematoxylin and eosin (H&E) [81] 3 di-
gital images acquired at 20×magnification and centralized nuclei and
fiber number were counted by a blinded investigator. For im-
munostaining, slides were removed from the freezer, fixed in 4% PFA
for 10min on ice, then incubated in 0.3% Triton-X100 in PBS for
10min. After rinsing with PBS sections were circled using a hydro-
phobic pen and incubated with 5% normal goat serum in PBS for
60min. Samples were then incubated with primary antibodies against
Ncam (Abcam, ab9018) and laminin (Chemicon MAB1928) diluted
1:100 in NGS overnight at 4 °C in a humidified chamber. Samples were
washed and incubated with fluorescently conjugated secondary anti-
bodies having been diluted 1:100 in NGS for 60min at RT. After a 10-
min incubation with 7.5 nM 4’,6-diamidino-2-phenylindole (DAPI), and
washing with PBS slides were mounted using vectashield and glass
coverslips. Images were acquired using Olympus Fluoview FV1000 with
identical parameters. The numbers of total fibers and fibers with in-
tracellular staining of Ncam were counted by a blinded investigator.
4.9. Biotin-switch
The biotin switch technique was employed to enrich S-nitrosylated
proteins in the GA and sciatic nerve as previously described [52].
Briefly, tissues were homogenized in 1:10mg tissue/mL lysis buffer
(50mM Tris HCL pH 7.5, 1mM EDTA, 150mM NaCl, 0.4% triton X-
100, 0.1 mM neocuproine + 1 protease inhibitor tablet in 50mL by 3
strokes at medium speed of polytron. To prove the effectiveness of
MitoSNO, we incubated a muscle in vitro with 100 µM MitoSNO with or
without 5mM DTT for 10min at 37 °C with shaking. Lysate was then
centrifuged at 4000 rpm for 15min at 4 °C and the pellet was discarded.
Protein concentration was determined using BCA assay (Pierce) and
100 µg of each sample was placed in 4 volumes of blocking buffer (9
volumes HEN+1 vol 25%SDS containing 20mM MMTS) for 1 h at
55 °C with shaking at 400 rpm. (note: equal concentrations of each
sample were saved to serve as input prior to blocking). HEN buffer.
Protein was precipitated by adding 2 volumes of ice-cold acetone and
placed at − 20 °C for 30min, spun at maximum, and the supernatant
was discarded. Protein was suspended in 25 µL of 4mM HPDP-biotin
and 1 µL of 100mM sodium ascorbate and incubated for 1 h at RT.
HPDP-biotin was removed by precipitation with 2 volumes of acetone
at − 20 °C for 30min then spun at maximum for 30min, the super-
natant was discarded and the pellet was resuspended in 100 µL HEN
buffer (250mM HEPES pH 7.7, 1 mM EDTA, 0.1mM neocuproine).
Then 200 µL of neutralization buffer (20mM HEPES pH 7.7, 10mM
NaCl, 1 mM EDTA, 0.5% Triton X-100) and 50 µL streptavidin agarose
(Sigma-Aldrich S1638) was added and samples were incubated at RT
for 1 h. Samples were then washed 5× with neutralization buffer
+ 600mM NaCl. Protein was eluted in 2× sample buffer (80mM Tris
HCl pH 6.8, 2% SDS, 10% glycerol, 0.0006% bromophenol blue, 0.1M
DTT) containing 1 protease inhibitor tablet, 100uL of each phosphatase
inhibitors, and equal volumes were loaded to a 10% SDS-Page gel.
Following electrophoresis transfer onto a nitrocellulose membrane, and
blocking with 5% dried milk, membranes was incubated with Rabbit
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anti-NDUFS1 (Thermo Scientific PA5-28220) 1:500, a cocktail of mouse
primaries against complexes I, II, III, IV, and V of the ETS (abcam
ab110413) 1:500, anti-4 Hydroxynonenal (abcam 48506) 1:1000, and
Rabbit anti-Actin (sigma A2066) 1:5000.
4.9.1. Mitochondrial isolation
Mitochondria were isolated from sciatic nerve and plantaris muscle
as previously described with slight modifications [49]. Tissues were
extracted after 3 h of IR and homogenized in fractionation buffer
(20mM HEPES, 250mM Sucrose, 0.1 mM EDTA, pH 7.4) by 3, 10 s
strokes, of a polytron at 40% power (1mg tissue:10 µL buffer). Im-
mediately after homogenization, samples were centrifuged for 800× g
for 10min at 4 °C. Homogenate was removed, transferred to a new tube,
and centrifuged 9000× g for 10min at 4 °C. resulting pellet was wa-
shed in fractionation buffer, centrifuged 9000× g for 10min at 4 °C and
resuspended in 2× sample buffer.
4.10. Statistical analysis
All results are presented as means ± Standard Error of the Mean
(SE). One-way analysis of variance was used to compare serum creatine
kinase, muscle mass, 14 day maximum specific force, centralized nu-
clei, NMJ denervation, MitoTimer red: green ratio, mitochondrial
content, and network fragmentation. Additionally, since there was no
interaction effect between nerve and muscle stimulated force produc-
tion at day 14 with MitoSNO treatment we performed a 1-way ANOVA
comparing treatments. Two-way analysis of variance was used to
compare force produced by nerve and muscle stimulation at different
time points (stimulation vs. time), and force of nerve and muscle sti-
mulation between treatment groups (stimulation vs. treatment). A sig-
nificant interaction of 0.05 was required to perform a between-variable
post-hoc analysis in which case Tukey's honestly significance difference
test was performed.
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